PD-1 signaling in T cells during chronic viral infection
PD-1 signaling in T cells during chronic viral infection
批准号:
8318855
负责人:
James L Riley
金额:
$49.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-09-01 至 2013-08-31
关键词:
AddressAffectAntigensAntiviral AgentsBindingBiological ModelsBiological ProcessCell physiologyCellsChronicChronic DiseaseComplexCytoplasmic TailDataDiseaseDistalGenerationsHIVHIV InfectionsHIV-1HumanITIMImage AnalysisImmune responseIn VitroInfectionLearningLigationLightLymphocytic choriomeningitis virusMediatingMemoryMolecularMusMutant Strains MiceMutationOutcomePTPN11 genePTPN6 genePeptide/MHC ComplexPhenotypePhysiologicalPlayPopulationPredispositionReagentRecruitment ActivityRegulationRelative (related person)Research PersonnelRoleSignal PathwaySignal TransductionSignaling MoleculeStagingStructureSynapsesSystemT cell differentiationT cell responseT memory cellT-Cell ActivationT-LymphocyteTechnologyTestingTransgenic MiceTyrosineVirus DiseasesWalkersbasecell typecytokineexhaustexhaustionexperiencein vivokillingsnovelpervanadateresponserestoration
中文摘要
慢性感染迫使T细胞分化成一种疲惫的状态,在这种状态下,它们仍然可以识别
抗原,但不能释放抗病毒剂和杀死感染的细胞。高表达的共抑制
分子PD-1是T细胞耗竭的标志。重要的是,PD-1阻断导致T
细胞效应子对耗尽的T细胞起作用。目前,有几个悬而未决的问题,
PD-1连接改变T细胞:参与后招募到PD-1胞质尾区的因子是什么?
PD-1在效应细胞和耗竭的T细胞中传递相同的信号吗?PD-1参与如何影响
T细胞产生多功能反应的能力PD-1信号转导的中断是否可以改变
T细胞耗竭的进展和易感性?这些问题将在本报告中得到解决。
应用和答案将揭示如何T细胞耗竭是强制性的,以及如何克服它。
我们的中心假设是PD-1连接在T细胞分化的不同阶段诱导不同的信号,
分化[(幼稚->效应器->记忆)与(幼稚->效应器->耗尽)]。我们的总体方法是
同时研究PD-1信号在小鼠和人类系统中的作用,使我们能够
利用每种系统的优势来探测PD-1功能,并破译是否存在任何关键差异。
目的1将检查在体外被募集到PD-1胞质尾区的因子,并将询问PD-1是如何在体外被激活的。
通过使用新试剂与PD-1结合,
由核心B提供的信号通路,并使用核心C提供的最新成像分析。目的
2建议检查PD-1信号传导在体内的作用,以便更好地理解PD-1如何在体内发挥作用。
接合导致并有助于T细胞耗竭。使用定义良好的LCMV模型系统,我们
将测试我们的假设,即不同的信号复合物在耗尽的T细胞中被招募到PD-1,
与效应T细胞和记忆T细胞相比。此外,核心B将产生小鼠,使我们能够
确定PD-1信号的改变如何影响对病毒感染的反应。在适当的情况下,我们会
与其他项目合作,研究PD-1连接改变的全球信号通路
(项目4)以及衰竭在控制艾滋病方面的作用(项目1)。通过这些
结合研究,我们希望了解PD-1连接如何阻断T细胞活化,导致T细胞耗竭,
表型,并发现目标,将恢复T细胞功能的慢性疾病,如HIV-1。
英文摘要
Chronic infection forces T cells to differentiate into a state of exhaustion in which they can still recognize
antigen but are unable to unleash antiviral agents and kill infected cells. High expression of the co-inhibitory
molecule PD-1 is the hallmark of T cell exhaustion. Importantly, .PD-1 blockade results in the restoration of T
cell effector functions to exhausted T cells. Presently, there are several outstanding questions regarding how
PD-1 ligation alters a T cell: What are the factors recruited to the PD-1 cytoplasmic tail after engagement?
Does PD-1 transmit the same signals in effector and exhausted T cells? How does PD-1 engagement affect
the T cell's ability to generate polyfunctional responses? Can disruption of PD-1 signaling alter the
progression to and susceptibility to T cell exhaustion? These are the questions that will be addressed in this
application and the answers will shed light on how T cell exhaustion is enforced and how it can be overcome.
Our central hypothesis is that PD-1 ligation induces distinct signals during various stages of T cell
differentiation [(naive -> effector ->memory) versus (naive ->effector -> exhausted)]. Our overall approach is
to study the effects of PD-1 signaling in both murine and human systems simultaneously, allowing us to
exploit the advantages of each system to probe PD-1 function and decipher if there are any key differences.
Aim 1 will examine the factors that are recruited to the PD-1 cytoplasmic tail in vitro and will ask how PD-1
engagement alters the generation of effector responses by employing novel reagents to engage PD-1
signaling pathways supplied by Core B and using state of the art imaging analysis provided by Core C. Aim
2 proposes to examine the effects of PD-1 signaling in vivo in order to better understand how PD-1
engagement leads to and contributes to T cell exhaustion. Using the well defined LCMV model system, we
will test our hypothesis that distinct signaling complexes are recruited to PD-1 in exhausted T cells as
compared to effector and memory T cells. Additionally, Core B will generate mice that will allow us to
determine how alterations in PD-1 signaling affect the response to viral infection. Where appropriate, we will
collaborate with the other projects in investigating the global signaling pathways altered by PD-1 ligation
(Project 4) as well as the role exhaustion plays in controlling HIV disease (Project 1). Through these
combined studies we expect to learn how PD-1 ligation blocks T cell activation, leads to the exhaustion
phenotype, and uncover targets that will restore T cell function to chronic diseases such as HIV-1.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core A: Administrative
-
批准号:10450646
-
项目类别:
-
资助金额:$7.93万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:10617364
-
项目类别:
-
资助金额:$97.8万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:10450651
-
项目类别:
-
资助金额:$97.41万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:9891737
-
项目类别:
-
资助金额:$99.66万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Core A: Administrative
-
批准号:9891733
-
项目类别:
-
资助金额:$8.1万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Core A: Administrative
-
批准号:10617344
-
项目类别:
-
资助金额:$8.15万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Modeling Combination Immunotherapy for HIV Cure in Humanized Mouse Models
-
批准号:10165498
-
项目类别:
-
资助金额:$97.82万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:10165491
-
项目类别:
-
资助金额:$280.79万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:9891732
-
项目类别:
-
资助金额:$287.15万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Core A: Administrative
-
批准号:10165492
-
项目类别:
-
资助金额:$8.09万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:10450645
-
项目类别:
-
资助金额:$269.92万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:10617343
-
项目类别:
-
资助金额:$242.19万
-
财政年份:2020
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:8899244
-
项目类别:
-
资助金额:$233.51万
-
财政年份:2015
-
负责人:James L Riley
-
依托单位:
Engineering T cells to Provide Durable Control of HIV-1 Replication
-
批准号:9052702
-
项目类别:
-
资助金额:$231.65万
-
财政年份:2015
-
负责人:James L Riley
-
依托单位:
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cells
-
批准号:9320900
-
项目类别:
-
资助金额:$46.3万
-
财政年份:2013
-
负责人:James L Riley
-
依托单位:
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cells
-
批准号:9109094
-
项目类别:
-
资助金额:$48.0万
-
财政年份:2013
-
负责人:James L Riley
-
依托单位:
Targeting the Persistent HIV-1 Viral Reservoir Using Engineered T cells
-
批准号:8462857
-
项目类别:
-
资助金额:$20.0万
-
财政年份:2013
-
负责人:James L Riley
-
依托单位:
Restoring HIV-1 Specific T cell Immunity
-
批准号:8062120
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2010
-
负责人:James L Riley
-
依托单位:
Restoring HIV-1 Specific T cell Immunity
-
批准号:8607906
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2010
-
负责人:James L Riley
-
依托单位:
Restoring HIV-1 Specific T cell Immunity
-
批准号:8609393
-
项目类别:
-
资助金额:$8.79万
-
财政年份:2010
-
负责人:James L Riley
-
依托单位:
海外基金